Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Trial Shows Synthetic Antibody Slows Cognitive Decline

neurons

Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease. . . . → Read More: Trial Shows Synthetic Antibody Slows Cognitive Decline

Small Biz Grant to Advance Cancer Chemotherapy Patch

Cancer on clipboard

A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors. . . . → Read More: Small Biz Grant to Advance Cancer Chemotherapy Patch

Nasal Spray Shown to Stop Covid-19 Infection, Disease

Nasal spray

An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines. . . . → Read More: Nasal Spray Shown to Stop Covid-19 Infection, Disease

Infographic – Vaccination Rates in Developed World

Chart: fully vaccinated

As most the world’s countries struggle to vaccinate their citizens against Covid-19, rates of fully vaccinated people in developed countries vary widely. . . . → Read More: Infographic – Vaccination Rates in Developed World

CEPI Funding Covid-19 Variant Vaccine

SARS-CoV-2 particle

A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine

Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Mature neuron

A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Psychedelic Therapy Company Raises $80M in New Funds

Psilocybe aztecorum

A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds

Biotechs Partner on Synthetic Plant-Based Drugs

Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs

Moderna to Build mRNA Vaccine Plant in Canada

Syringes

The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada

Gates Grant Funds HIV-Birth Control Implant

T-cell infected by HIV

A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women. . . . → Read More: Gates Grant Funds HIV-Birth Control Implant